Previous 10 | Next 10 |
2024-03-07 13:29:15 ET More on AstraZeneca, CSL, etc. Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript) GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy CSL Limited: Earnings Beat Doesn't Mask Unfavorable Trial Results (Downgr...
2024-03-06 17:49:17 ET Moderna, Inc. (MRNA) TD Cowen 44th Annual Health Care Conference March 06, 2024 01:30 PM ET Company Participants Stephen Hoge - President Conference Call Participants Tyler Van Buren - TD Cowen Presentation Tyler Van Buren...
2024-03-06 16:16:26 ET More on Metagenomi, Inc. Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps Metagenomi Begins Genetic Treatment IPO Rollout Moderna-backed Metagenomi sees stock fall 31% after $94M IPO Metagenomi prices initial off...
2024-03-05 08:09:09 ET More on BioNTech, Moderna, etc. Pfizer Inc. (PFE) TD Cowen 44th Annual Health Care Conference 6%-Yielding Pfizer Is An Ultra-Deep-Value Gem In An Expensive Market Novavax: Another Day Older And Deeper In Biden to launch task force to ta...
2024-03-03 13:17:00 ET Moderna (NASDAQ: MRNA) was a top stock to own during the early stages of the pandemic. The COVID-19 vaccine maker reached a market cap of nearly $200 billion at its peak in 2021. But nowadays, with revenue from its vaccine diminishing and no longer being a str...
2024-03-02 13:10:00 ET The past four years have been a roller-coaster ride for Moderna (NASDAQ: MRNA) . The mRNA-focused vaccine maker rose to prominence following a successful attempt at developing a coronavirus vaccine. However, the stock fell out of favor once sales of the co...
2024-03-02 09:30:00 ET You can find growth stocks in every sector. With healthcare making up nearly one-fifth of the U.S. economy, it's a great place to look. Three Motley Fool contributors have identified what they think are magnificent growth stocks to buy in March -- and all of them ...
CAMBRIDGE, MA / ACCESSWIRE / February 29, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host its fifth annual Investor Event focused on vaccines and business updates on Wednesday, March 27, 2024. The presentation will begin at 9:00 a.m. ET. Moderna's Investor Event will includ...
2024-02-29 05:50:00 ET You've no doubt seen mutual fund warnings that past performance isn't necessarily indicative of future results. This caution applies to stocks as well. However, it doesn't just mean that investments that have performed well in the past may not keep winning; it also im...
2024-02-28 07:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...